XCELLCURE

XCellCure is a startup biotechnology company focused on transforming modern cardiac care by enabling quantitative, low-cost prevention. With the launch of our first product, the AMiAware Human Cardiovascular Disease Microarray, our product line aids the prevention of recurrent heart attack through patient-centered risk stratification utilizing 13 novel biomarkers. The motif of our clinical approach is to noninvasively diagnose and prognosticate patients experiencing acute coronary symptoms in order to assist in patient monitoring, aid therapeutic selection, prevent fatality, and reduce morbidity of cardiovascular disease. We are releasing a collection of cardiac devices for the research, clinical and point of care realms to supplement and improve current care and patient quality of life... XCellCure is a biotechnology start up revolutionizing the way the world treats heart attacks. Our product line of cardiac panels includes patented prognostic markers which provide a patient-specific..

Also known as: XCellCure, LLC

Primary location: Louis United States